Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/2012
08/09/2012WO2010121213A3 Antibacterial compositions
08/09/2012US20120204280 Drg11-responsive (dragon) gene family
08/09/2012US20120204278 Animal models and therapeutic molecules
08/09/2012US20120204277 Non-Aggregating Fluorescent Proteins and Methods for Using the Same
08/09/2012US20120204275 Apoe immunotherapy
08/09/2012US20120202977 Single domain antibodies directed against tumor necrosis factor-alpha and uses therefor
08/09/2012US20120202975 Elution of proteins from hydroxyapatite resins without resin deterioration
08/09/2012US20120202974 Process for the purification of fc-containing proteins
08/09/2012US20120202739 Gdf3 antibodies and related methods
08/09/2012US20120202732 Modified aav capsid polypeptides
08/09/2012US20120202710 Methods and compositions for generation of germline human antibody genes
08/09/2012US20120202701 An antibody-glycan complex targeting the disialyl core ii and sialyl lewis x structures, and uses thereof involving analysis of stem cells or cancer cells
08/09/2012US20120202247 Method, computing routine, device for predicting properties of mhc/peptide complexes, and data and peptides produced therefrom
08/09/2012US20120202244 Antibodies Capable of Specifically Binding to a Specific Amino Acid Sequence
08/09/2012US20120202208 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
08/09/2012US20120202207 Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma
08/09/2012US20120202206 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors
08/09/2012US20120201841 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein
08/09/2012US20120201837 Use of eif3m for the diagnosis and treatment of cancer
08/09/2012US20120201835 Antibodies specific for dkk-1
08/09/2012US20120201834 POLY-N-ACETYL GLUCOSAMINE (PNAG/dPNAG)-BINDING PEPTIDES AND METHODS OF USE THEREOF
08/09/2012US20120201833 POLY-N-ACETYL GLUCOSAMINE (PNAG/dPNAG)-BINDING PEPTIDES AND METHODS OF USE THEREOF
08/09/2012US20120201831 Human antibodies that bind human il-12 and methods for producing
08/09/2012US20120201829 Human Monoclonal Antibody Against S. Aureus Derived Alpha-Toxin and Its Use in Treating or Preventing Abscess Formation
08/09/2012US20120201828 Antibodies that specifically bind to the epha2 receptor
08/09/2012US20120201827 Anti-cd38 antibodies
08/09/2012US20120201826 Anti-RANTES Antibodies and Methods of Use Thereof
08/09/2012US20120201825 Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection
08/09/2012US20120201824 Compositions and Methods for Inhibiting an Oncogenic Protein to Enhance Immunogenicity
08/09/2012US20120201821 Treatment of Gastrointestinal Inflammation and Psoriasis and Asthma
08/09/2012US20120201820 Immunological compositions as cancer therapeutics
08/09/2012US20120201818 Treatment of multiple sclerosis
08/09/2012US20120201817 Methods of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular antagonist
08/09/2012US20120201811 Generation and use of fab, scfv, and related binding molecules specific for hiv-1 rev
08/09/2012US20120201809 Multifunctional antibody conjugates
08/09/2012US20120201792 Methods and products for manipulating hematopoietic stem cells
08/09/2012US20120201756 Plasma kallikrein binding proteins
08/09/2012US20120201752 Foxc1 antibodies and methods of their use
08/09/2012US20120199516 Method for treating multiple sclerosis
08/09/2012US20120199483 Nanopore capture system
08/09/2012CA2826186A1 Human antibodies and antibody-drug conjugates against cd74
08/09/2012CA2826144A1 Foxc1 antibodies and methods of their use
08/09/2012CA2825990A1 Anti-tace antibody molecules and their uses
08/09/2012CA2825651A1 Apatite surface neutralization with alkali solutions
08/09/2012CA2825064A1 Fc variants and methods for their production
08/08/2012EP2484774A2 Multiple gene expression including sorf contructs and methods with polyproteins, pro-proteins, and proteolysis
08/08/2012EP2484763A2 Neukinase, a downstream protein of neuregulin
08/08/2012EP2484761A1 Dna construct, and process for production of recombinant cho cell using same
08/08/2012EP2484756A1 Novel pacemaker cell
08/08/2012EP2484698A1 Hybridoma producing anti-methylated dna antibody and utilization of same
08/08/2012EP2484697A1 Anti-podoplanin antibody, and pharmaceutical composition containing anti-podoplanin antibody
08/08/2012EP2484696A1 Antagonistic human light-specific human monoclonal antibodies
08/08/2012EP2484695A1 A method for the production of hybridoma cell lines producing monoclonal antibodies capable to specifically binding to a human C44-fragment of agrin
08/08/2012EP2484694A1 Monoclonal antibody against human hig-1 polypeptide
08/08/2012EP2484693A1 Human serum amyloid-a3 antibody and use thereof
08/08/2012EP2484689A1 Peptide inhibiting differentiation of hematopoietic stem cells or hematopoietic precursor cells and use of same
08/08/2012EP2484380A1 Molecules that are able to inhibit the binding between NGF and the TrkA receptor as analgesics with prolonged effect
08/08/2012EP2484379A1 Agent for prevention of atherosclerosis
08/08/2012EP2483416A1 Monoclonal antibodies
08/08/2012EP2483407A2 Methods for modulation of autophagy through the modulation of autophagy-enhancing gene products
08/08/2012EP2483316A1 Anti-fibroblast activation protein antibodies and methods and uses thereof
08/08/2012EP2483315A2 Conjugates targeting the cd163 receptor
08/08/2012EP2483314A1 Bispecific binding molecules for anti-angiogenesis therapy
08/08/2012EP2483313A2 Dll4-binding molecules
08/08/2012EP2483312A1 Antibodies that specifically bind to the epha2 receptor
08/08/2012EP2483311A2 Methods of treating cancer using notch antagonists
08/08/2012EP2483310A1 Bispecific death receptor agonistic antibodies
08/08/2012EP2483309A1 Antibodies specifically binding to the epidermal growth factor receptor
08/08/2012EP2483308A1 Drug fusions and conjugates with extended half life
08/08/2012EP2483307A1 Influenza hemagglutinin antibodies, compositions, and related methods
08/08/2012EP2483306A2 Anti-hsv antibody
08/08/2012EP2483305A1 Multistep final filtration
08/08/2012EP2483304A1 Pre-filtration adjustment of buffer solutes
08/08/2012EP2483301A1 Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer
08/08/2012EP2482854A2 Agents, uses and methods
08/08/2012EP2482849A2 Combination immunotherapy for the treatment of cancer
08/08/2012EP2482848A1 Endoglin antibodies
08/08/2012EP2482825A1 Piscine reovirus diagnostic compositions
08/08/2012EP2482824A1 Piscine reovirus immunogenic compositions
08/08/2012EP2482814A1 Methods and compositions for treatment of ocular fibrosis
08/08/2012EP2159577B1 Novel marker for arteriosclerotic disease
08/08/2012EP2152753B1 Antibodies against ramp3
08/08/2012EP1690550B1 Therapeutic agent for mesothelioma
08/08/2012EP1585760B1 Btl-ii nucleic acids, proteins, and antibodies
08/08/2012EP1569685B1 Complement receptor 2 targeted complement modulators
08/08/2012EP1492818B1 Anti-tirc7 antibodies and tnf-alpha antagonists in combination -therapy of inflammatory diseases
08/08/2012EP1127148B1 Variants of humanized anti-carcinoma monoclonal antibody cc49
08/08/2012EP0951551B2 Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily
08/08/2012CN1930288B Cells of which genome is modified
08/08/2012CN1901936B Cytotoxicity mediation of cells evidencing surface expression of cd44
08/08/2012CN1576281B Viral clearance process
08/08/2012CN102630229A Treating notch1-antagonist-resistant cancer (s) using notch3 antagonists
08/08/2012CN102628191A Method for preparing and constructing Ab2belta antibody library capable of resisting infection of various known and unknown respiratory viruses
08/08/2012CN102627697A Anti-human colorectal cancer stem cell related protein LYRM2 (LYR motif containing 2) monoclonal antibody and application
08/08/2012CN102627628A Chlorantraniliprole antigen, its preparation method and application
08/08/2012CN101899110B Method for separating immune globulin IgY(delta Fc) from goose blood
08/08/2012CN101688200B Sequence based engineering and optimization of single chain antibodies
08/08/2012CN101611055B Human antibodies to human DELTA like ligand 4
08/08/2012CN101580534B CpTI enzyme-linked immunoassay reagent kit as well as preparation method and application thereof
08/08/2012CN101454345B High affinity antibodies to human il-6 receptor
1 ... 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 ... 1494